Institutional investors hold a majority ownership of ABBV through the 71.83% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended March 2018, these large investors purchased a net $5.9 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARROWSTREET CAPITAL LP Bought 6.1 Million shares of AbbVie Inc
HENDERSON GLOBAL INVESTORS LTD. Bought 4.5 Million shares of AbbVie Inc
MANAGED ACCOUNT ADVISORS LLC Bought 3.9 Million shares of AbbVie Inc